Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

Nature 1993;362:801–809. 5. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095–4103. 6. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunan JK, Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary artery disease and acute myocardial infarction. Lancet 1988;2:983–986. 7. Campbell LA, O’Brien ER, Cappuccio AL, Kuo CC, Wang S, Stewart D, Patton DL, Cummings PK, Graystone JT. Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Infect Dis 1995;172:585–588. 8. Muhlestein JB, Hammond EH, Cariquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555–1561. 9. Ramirez JA, The Chlamydia pneumoniae Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae (TWAR) from the coronary arteries of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979–982. 10. Paterson DL, Hall J, Rasmussen SJ, Timms P. Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australien patients. Pathology 1998; 30:169–172. 11. Ouchi K, Fujii B, Kudo S, Shirai M, Yamashita K, Gondo T, Ishihara T, Ito H, Nakazawa T. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J Infect Dis 2000;181(suppl 3):441–443. 12. Bauriedel G, Welsch U, Likunga JA, Welz A, Luderitz B. Chlamydia pneumoniae in coronary plaques: increased detection with acute coronary syndrome. Dtsch Med Wochenschr 1999;124:375–380. 13. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM, Leinonen Mkairalouma MI, Saikku P. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997;25:499–505. 14. Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999;34:1435– 1439. 15. Maass M, Jurgen J, Gieffers J, Dalhoff K, Katus HA, Solbach W. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis 2000;181(suppl):S449–S451. 16. Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999;34:1435– 1439. 17. Nissen SF, Gurley JC. Assessments of coronary angioplasty results by intravascular ultrasound. In: Serruys PW, Strauss BH, King SB, eds. Restenosis After Intervention With New Mechanical Devices. Dordrecht, The Netherlands: Kluwer Academic, 1992:73–96. 18. Tiran A, Tio RA, Ossewaarde JM, Tiran B, den Heijer P, The TH, WildersTruschnig MM. Coronary angioplasty induces rise in Chlamydia pneumoniaespecific antibodies. J Clin Microbiol Inf Dis 1999;37:1013–1017. 19. Smieja M, Chong S, Natarajan M, Petrich A, Rainen L, Mahony JB. Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography. J Clin Microbiol 2001;39:596–600.